Gender differences in risk factors for aberrant prescription opioid use.

Pain Management Center, Departments of Anesthesia and Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02467, USA.
The journal of pain: official journal of the American Pain Society (Impact Factor: 4.22). 11/2009; 11(4):312-20. DOI: 10.1016/j.jpain.2009.07.016
Source: PubMed

ABSTRACT This is a longitudinal predictive study to examine gender differences in the clinical correlates of risk for opioid misuse among chronic pain patients prescribed opioids for pain. Two hundred seventy-five male and 335 female patients prescribed opioids for chronic noncancer pain were asked to complete a series of baseline questionnaires, including the revised Screener and Opioid Assessment for Pain Patients (SOAPP-R). After 5 months, the subjects were administered a structured prescription drug use interview (Prescription Drug Use Questionnaire; PDUQ) and submitted a urine sample for toxicology assessment. Their treating physicians also completed a substance misuse behavior checklist (Prescription Opioid Therapy Questionnaire; POTQ). At 5-month follow-up, women showed higher scores on the PDUQ (P < .05), whereas men had a higher incidence of physician-rated aberrant drug behavior on the POTQ (P < .05). An item analysis of the SOAPP-R, PDUQ, and POTQ showed that women tended to score higher on items relating to psychological distress, whereas the male patients tended to report having more legal and behavioral problems. These results suggest that risk factors associated with prescription opioid misuse may differ between men and women. PERSPECTIVE: Understanding gender differences in substance abuse risk among chronic pain patients is important for clinical assessment and treatment. This study suggests that women are at greater risk to misuse opioids because of emotional issues and affective distress, whereas men tend to misuse opioids because of legal and problematic behavioral issues.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Nonmedical Prescription Drug Use (NMPDU) is a growing issue world-wide. Previously, NMPDU comorbidity has been investigated using bivariate approaches, providing a piecemeal understanding of NMPDU's relationship to other mental disorders. We investigate how NMPDU fits within the multivariate meta-structure of psychiatric comorbidity and how this might vary as a function of gender. Data were collected as part of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) in 2001-2002 on 43,093 individuals 18 years or older living in the US. The Alcohol Use Disorder and Associated Disabilities Interview Schedule DSM-IV version IV (AUDADIS-IV) assessed psychiatric diagnoses and sedative, tranquilizer, opioid, and amphetamine NMPDU. Using confirmatory factor analysis, NMPDU was introduced into the internalizing-externalizing model of common mental disorders to determine where it best fits. Models were examined separately for men and women and tested for gender invariance. NMPDU was strongly associated with the externalizing factor, and also showed a very small secondary association with the fear subfactor of internalizing. This structure was gender invariant. Differences between men and women's prevalence rates originate at the level of the latent factors. Results indicate a shared liability to NMPDU and other forms of externalizing psychopathology such as other substance use disorders, as well as antisocial behaviors. Research on NMPDU can benefit from focusing on the externalizing factor, aiming to understand how risk factors for diverse externalizing disorders may also manifest as NMPDU. Prescribers should be particularly attentive to the presence of the entire spectrum of externalizing disorders, as they may signal risk for NMPDU.
    Journal of Psychopathology and Behavioral Assessment 09/2014; 36(3):371-379. DOI:10.1007/s10862-014-9409-2 · 1.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent increases in the nonmedical use of pharmaceutical opioids and the adverse outcomes associated with them have stimulated a large amount of research and data collection on this public health problem. Systematic organization of the available data sources is needed to facilitate ongoing research, analysis, and evaluation. This work offers a systematic categorization of data sources regarding the nonmedical use of pharmaceutical opioids in the United States. A list of keywords regarding the nonmedical use of pharmaceutical opioids was used to conduct systematic searches in PubMed®. Filtration of search results generated 92 peer-reviewed academic articles, published between January 1995 and April 2012, as well as a number of primary data sources. Lists of topics were developed independently by two researchers which were later compared and consolidated. All sources were then categorized according to their relevance to each of these topics and according to their capacity for geographical and longitudinal trend analysis. Tables cataloging data sources can be used to identify data relevant to specific topics in diversion, nonmedical use, and adverse outcomes associated with pharmaceutical opioids, and they illustrate global trends in data coverage, identifying several topics that have minimal data. A network diagram illustrates global trends in data coverage, showing variation among sources in the number of topics they cover, as well as variation among topics in the number of sources that cover them. The categorization of data sources is hoped to facilitate ongoing research, analysis, and evaluation of this public health problem by serving as a guide for researchers, policy makers, and others who seek data regarding the nonmedical use of pharmaceutical opioids in the United States.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To the best of the authors' knowledge, gender differences in nonmedical opioid presentations to the emergency department (ED) have not been studied. The objective was to explore gender differences in ED visits related to nonmedical prescription opioid use in a nationally representative sample. Se analizaron los datos desde 2001 del Department of Health and Human Services Substance Abuse and Mental Health Services Administration's Drug Abuse Warning Network (DAWN) para comparar las características entre las visitas entre varones y mujeres. Se desarrollaron modelos de regresión logística para examinar la asociación entre el género y las atenciones específicas por drogas y los resultados clínicos. Hubo una estimación de 426.010 visitas definidas por DAWN involucradas con la prescripción de fármacos opiáceos en 2011. La prevalencia de fármacos en las visitas relacionadas con fármacos opiáceos fue similar entre las mujeres y los varones. La ingestión de otro fármaco junto con los fármacos opiáceos se asoció con un riesgo incrementado de ingreso hospitalario tanto para las mujeres como para los varones, y los tipos de fármacos opiáceos ingeridos fueron similares entre las mujeres y los varones. Sin embargo, hubo diferencias entre géneros en los resultados clínicos dependiendo de la combinación específica de fármacos. Las diferencias de género existen en la atenciones en el SU relacionadas con la prescripción de opiáceos. Se precisa de futuras investigaciones para comprender estas diferencias y cualquiera de sus implicaciones en la atención de urgencias específicas de género e intervenciones breves. Spanish Según el conocimiento de los autores, las diferencias de género en las atenciones no médicas al Servicio de Urgencias (SU) no se han estudiado. El objetivo fue explorar las diferencias en función del género en las visitas relacionadas con el uso de opiáceos no prescritos por médicos en un muestra representativa nacional.
    Academic Emergency Medicine 12/2014; 21(12). DOI:10.1111/acem.12547 · 2.20 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014